Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien-Ching Hung

Showing results (351-360 of 388) with videos related to

Pageof 39
Sort By:
International Journal of Antimicrobial Agents|July 21, 2021
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIVYu-Lin Lee, Kuan-Yin Lin, Shu-Hsing Cheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2009
Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in hiv-infected individuals in TaiwanSui-Yuan Chang, Wei-Shin Ko, Jau-Tsuen Kao, et al.
Scientific Reports|September 27, 2022
Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-upKuan-Yin Lin, Chia-Jui Yang, Hsin-Yun Sun, et al.
Scientific Reports|September 14, 2018
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational studyChen-Hua Liu, Yi-Jie Huang, Sien-Sing Yang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2020
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Bo-Huang Liou, et al.
Microbiology Spectrum|March 29, 2023
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, et al.
IJID Regions|March 11, 2026
Exploring HIV care disparities among foreigners in Taiwan: Insights from a multicenter study (2017-2023)Sung-Hsi Huang, Shu-Ying Chang, Bo-Huang Liou, et al.
International Journal of Antimicrobial Agents|July 5, 2022
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimensGuan-Jhou Chen, Hsin-Yun Sun, Ling-Ya Chen, et al.
Plos One|July 1, 2017
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-upKuan-Yin Lin, Chien-Yu Cheng, Chia-Wen Li, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 30, 2024
Hypogonadism among HIV-positive men who have sex with men in Taiwan: Prevalence and associated factorsKuan-Yu Lin, Hsin-Yun Sun, Wang-Da Liu, et al.
Pageof 39

Showing results (351-360 of 388) with videos related to

Sort By:
Pageof 39
International Journal of Antimicrobial Agents|July 21, 2021
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIVYu-Lin Lee, Kuan-Yin Lin, Shu-Hsing Cheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2009
Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in hiv-infected individuals in TaiwanSui-Yuan Chang, Wei-Shin Ko, Jau-Tsuen Kao, et al.
Scientific Reports|September 27, 2022
Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-upKuan-Yin Lin, Chia-Jui Yang, Hsin-Yun Sun, et al.
Scientific Reports|September 14, 2018
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational studyChen-Hua Liu, Yi-Jie Huang, Sien-Sing Yang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2020
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Bo-Huang Liou, et al.
Microbiology Spectrum|March 29, 2023
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, et al.
IJID Regions|March 11, 2026
Exploring HIV care disparities among foreigners in Taiwan: Insights from a multicenter study (2017-2023)Sung-Hsi Huang, Shu-Ying Chang, Bo-Huang Liou, et al.
International Journal of Antimicrobial Agents|July 5, 2022
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimensGuan-Jhou Chen, Hsin-Yun Sun, Ling-Ya Chen, et al.
Plos One|July 1, 2017
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-upKuan-Yin Lin, Chien-Yu Cheng, Chia-Wen Li, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 30, 2024
Hypogonadism among HIV-positive men who have sex with men in Taiwan: Prevalence and associated factorsKuan-Yu Lin, Hsin-Yun Sun, Wang-Da Liu, et al.
Pageof 39